Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma
Phase II Trial of Anti-Angiogenic Therapy With RT-PEPC in Patients With Relapsed Mantle Cell Lymphoma
Weill Medical College of Cornell University